Pliant Therapeutics (PLRX) Treasury Shares (2019 - 2026)
Pliant Therapeutics (PLRX) reported Treasury Shares of $557456.0 for Q1 2026, down 58.62% year-over-year from $1.3 million in Q1 2025, and down 35.05% quarter-over-quarter from $858247.0 in Q4 2025.
Pliant Therapeutics (PLRX) Treasury Shares (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 8 years of Treasury Shares data on file, last reported at $557456.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $557456.0, down 58.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $557456.0 (down 58.62% YoY), and the FY2025 annual result was $858247.0, down 7.98% from the prior year.
- Treasury Shares eased to $557456.0 in Q1 2026 per PLRX's latest filing, from $858247.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.3 million in Q1 2025 and troughed at $6235.0 in Q1 2022.
- A 5-year average of $846547.8 and a median of $941880.5 in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2023: Treasury Shares tumbled 93.52% in 2022, then surged 18641.56% in 2023.
- A 5-year view of Treasury Shares shows it stood at $354532.0 in 2022, then jumped by 146.73% to $874748.0 in 2023, then advanced by 6.62% to $932634.0 in 2024, then dropped by 7.98% to $858247.0 in 2025, then sank by 35.05% to $557456.0 in 2026.
- Business Quant data shows PLRX's Treasury Shares at $557456.0 in Q1 2026, $858247.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Pliant Therapeutics | 74.16 Mn | 74.16 Mn | - | 557,456.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 557,456.00 |
| Mar 31, 2026 | 557,456.00 |
| Dec 31, 2025 | 858,247.00 |
| Dec 31, 2025 | 858,247.00 |
| Sep 30, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 932,634.00 |
| Dec 31, 2024 | 932,634.00 |
| Sep 30, 2024 | 951,127.00 |
| Sep 30, 2024 | 951,127.00 |
| Jun 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 874,748.00 |
| Dec 31, 2023 | 874,748.00 |